Andrew Eschenbach Quotations

FDA continues to warn consumers to avoid consumption of dietary supplements containing ephedrine alkaloids. We will continue to do all we can to protect the public health against these dietary supplements that have been found to cause serious illness and injury.

One of the biggest barriers research and academic institutions face is the ability to get discoveries made in the lab into clinical testing. The new Exploratory IND guidance emphasizes the flexibility available to researchers when conducting early clinical testing of these cutting-edge treatments. As we enter the era of personalized medicine, these exploratory approaches enable scientists to take full advantage of new technologies to target the development of more individualized therapies.

There are initiatives in place to deter counterfeiters and those who sell fraudulent or phony products to prevent or treat avian flu. The use of unproven flu cures and treatments increases the risk of catching and spreading the flu rather than lessening it because people assume they are protected and safe and they aren't. I consider it a public health hazard when people are lured into using bogus treatments based on deceptive or fraudulent medical claims.

This new guidance level will further reduce an already minimal risk from lead exposure in candy.

Fresh cut produce is the fastest growing sector of the fresh produce industry. This document should help to improve safety by providing clearer guidance on how to reduce health hazards that are potentially introduced during the production process.

The new label design makes it easier for doctors to get access to important information about drug safety and benefits, and this in turn will help them have more meaningful discussions with their patients. This redesigned label is a big step in our commitment to giving health professionals the tools and information they need to optimize their clinical practice and choose among a growing number of effective treatments to make more personalized prescribing decisions for their patients.

The National Cancer Institute wants to make certain the results of clinical research are rapidly disseminated to healthcare providers and patients, to ensure life-enhancing cancer treatments are widely available.